Melatonin Supplementation and Performance (MSP)

August 18, 2016 updated by: kais

Nocturnal Melatonin Ingestion Ameliorates Short Term Maximal Performances on the Following Day

The present study aimed to evaluate the possible effect of nocturnal melatonin ingestion upon short-term performances, on the following morning. Twelve soccer players from a Tunisian squad (22.9 ±1.3 years, 1.80±0.05 m, and 72.0±8.8 kg) were volunteered to perform three testing sessions, with one test session per day. During each session, MEL (5mg) , MEL (8mg) or placebo were ingested, in a randomized order, before nocturnal sleep. The next morning (08:00h), participants performed the following psycho-cognitive and physical tests: Hooper's index, reaction time, vigilance, handgrip strength , squat jump , modified agility test , Wingate anaerobic test (peak power , mean power and fatigue index ). Rating of perceived exertion was recorded immediately after the WanT, and blood lactate measures were taken after 3min of recovery. Blood glucose was measured before and 3 min after the Wingate test.

Study Overview

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Early Phase 1

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 23 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

The participants were recruited based on the following criteria: (i) paticipants must be trained at 4-6 days per week for an average of 2 h daily and (ii) they must have at least 8 years of training experience

Exclusion Criteria:

  • Subjects were excluded from the study if they present one of the following criteria : heart failure, antioxidant supplementation within 3 months before the study, lower-limb injuries

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo
In a double-blind randomized design, participants have taken placebo supplementation in one of the three experimental sessions
Experimental: Melatonin
Our protocol was composed of three experimental sessions. During each testing session, participants were requested to attend the laboratory at 20:00h where they ingested a standardized light meal. Melatonin (5 mg or 8 mg) or placebo were ingested in capsule in the evening at 21:00h in a double-blind randomized design

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hooper's index score
Time Frame: At 07:30 am in the following day of the supplementation
Hooper's index score was measured using a specific questionnaire
At 07:30 am in the following day of the supplementation
handgrip strength (in Kg)
Time Frame: At 07:30 am in the following day of the supplementation
handgrip strength was measured using a calibrated hand dynamometer.
At 07:30 am in the following day of the supplementation
Blood lactate (µmol/l)
Time Frame: Blood lactate was measured only 3 minutes after physical testing in the following day of the supplementation
Lactate level was measured using Lactate Pro instrument.
Blood lactate was measured only 3 minutes after physical testing in the following day of the supplementation
reaction time (in secondes)
Time Frame: At 07:30 am in the following day of the supplementation
Reaction time was measured using an electronic timing device.
At 07:30 am in the following day of the supplementation
vigilance score
Time Frame: At 07:30 am in the following day of the supplementation
Vigilance score was measured using a specific questionnaire
At 07:30 am in the following day of the supplementation
squat jump (in centimeters)
Time Frame: At 07:30 am in the following day of the supplementation
Squat jump was assessed using a infrared jump system
At 07:30 am in the following day of the supplementation
agility (in secondes)
Time Frame: At 07:30 am in the following day of the supplementation
Agility was assessed using an electronic timing system.
At 07:30 am in the following day of the supplementation
anaerobic capacity (In watts)
Time Frame: At 07:30 am in the following day of the supplementation
Anaerobic capacity was assessed using a calibrated friction-loaded cycle ergometer
At 07:30 am in the following day of the supplementation
glucose level (µmol/l)
Time Frame: At 07:30 am in the following day of the supplementation (rest condition) and 3 minutes after physical testing in each experimental session
Glucose level was assessed using a glucometer
At 07:30 am in the following day of the supplementation (rest condition) and 3 minutes after physical testing in each experimental session
Rating of perceived exertion score
Time Frame: Rating of perceived exertion score was measured 3 minutes after physical testing in the following day of the supplementation
Rating of perceived exertion score was measured using a specific questionnaire
Rating of perceived exertion score was measured 3 minutes after physical testing in the following day of the supplementation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2012

Primary Completion (Actual)

January 1, 2013

Study Completion (Actual)

January 1, 2013

Study Registration Dates

First Submitted

August 2, 2016

First Submitted That Met QC Criteria

August 18, 2016

First Posted (Estimate)

August 24, 2016

Study Record Updates

Last Update Posted (Estimate)

August 24, 2016

Last Update Submitted That Met QC Criteria

August 18, 2016

Last Verified

August 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Motor Activity

Clinical Trials on Experimental: Melatonin

3
Subscribe